Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by StockNews.com

StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently weighed in on ONCT. Oppenheimer downgraded Oncternal Therapeutics from an outperform rating to a market perform rating […]

Related Keywords

San Diego ,California ,United States ,Davidf Hale ,Jamesb Breitmeyer , ,Ci Private Wealth ,Securities Exchange Commission ,Richmond Brothers Inc ,Cantor Fitzgerald ,Oncternal Therapeutics Inc ,Waypoint Capital Advisors ,Maxim Group ,Millennium Management ,Susquehanna International Group ,Oncternal Therapeutics ,Get Rating ,Capital Acquisition ,Capital Management ,Therapeutics Trading Down ,Exchange Commission ,International Group ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,